Dr. Andrew Yoo and Samantha Morris New Publication
Congratulations to Dr. Andrew Yoo and Samantha Morris on their new publication! Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by MicroRNAs. Cates K, McCoy MJ, Kwon JS, Liu Y, Abernathy DG, Zhang B, Liu S, Gontarz P, Kim WK, Chen S, Kong W, Ho JN, Burbach KF, Gabel HW, Morris SA, Yoo AS. […]
Dr. Covey’s New Publication
Congratulations to Dr. Doug Covey’s Lab on their new publication! Site-specific effects of neurosteroids on GABAA receptor activation and desensitization. Sugasawa Y, Cheng WW, Bracamontes JR, Chen ZW, Wang L, Germann AL, Pierce SR, Senneff TC, Krishnan K, Reichert DE, Covey DF, Akk G, Evers AS. Elife. 2020 Sep 21;9:e55331.
Dr. Stacey Rentschler’s New Publication
Congratulations to Dr. Stacey Rentschler’s Lab on their recent publication! Chamber-specific transcriptional responses in atrial fibrillation. Lipovsky CE, Jimenez J, Guo Q, Li G, Yin T, Hicks SC, Bhatnagar S, Takahashi K, Zhang DM, Brumback BD, Goldsztejn U, Nadadur RD, Perez-Cervantez C, Moskowitz IP, Liu S, Zhang B, Rentschler SL. JCI Insight. 2020 Sep 17;5(18):e135319.
Startup company founded by WU scientists acquired by Eli Lilly (Links to an external site)
“Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine in St. Louis. Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.” Congratulations to Dr. Aaron DiAntonio! […]
Dr. Rentschler was selected to be funded by Additional Ventures
Congratulations Dr. Stacey Rentschler! Dr. Rentschler has been selected as one of 8 multi-disciplinary investigators to be funded by Additional Ventures to work together towards a cure for single ventricle heart disease using regenerative medicine approaches. Additional Ventures has committed $2 million per year for 5 years to fund this initiative.
Aaron DiAntonio has received a Javits award through the NIH
Congratulations to Dr. Aaron DiAntonio!
Aaron DiAntonio, M.D., Ph.D., Alan A. and Edith L. Wolff Professor of Developmental Biology has received a four-year $2,393,212 Javits award through the National Institutes of Health, National Institute of Neurological Disorders and Stroke beginning August 1, 2020, for his project entitled “Regulation of axonal degeneration by the DLK kinase”.